FREMONT, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Cytek ® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial ...

The company is initiating 2026 revenue guidance of $205 million to $212 million, assuming constant currency exchange rates and no significant change in tariffs. McCombe explained, "This guidance range ...

Cytek Biosciences, Inc. is a life sciences technology company, which engages in the provision of cell analysis tools by leveraging novel technical approaches. Its products include Cytek Aurora CS, ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in 1993 in Alexandria, VA., by brothers David and Tom ...

Cytek Biosciences, Inc. (CTKB) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of $0.02. This compares to earnings of $0.07 per share a year ago. These figures ...

Cytek Biosciences missed estimated earnings by -3300.0%, reporting an EPS of $-0.34 versus an estimate of $-0.01. Revenue was up $4.67 million from the same period last year. During the previous ...

Wenbin Jiang, President, CEO & Chairman of the Board, stated that "Fourth quarter revenue in 2025 reached $62.1 million, representing a year-over-year increase of 8% compared to the same period in ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. NOAA is forecasting an uptick in space weather, with the aurora borealis possible from ...

In 2024, La Plaza, a sprawling Latin marketplace with 125 vendors, debuted in the former Super K-Mart at 15200 East Colfax in Aurora. The project had been in the works for nearly four years by the ...